News
News from us and our partners
Tags
Topics
0 results
- News
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
- News
Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline
- News
Mane expands partnership with Arzeda to accelerate global commercialization of Vialeaf™ REB M
- News
Elevara Medicines appoints biotech veteran as CEO
- News
Sofinnova Partners appoints David Evans as Partner
- News
Tenpoint Therapeutics Announces United Kingdom YUVEZZI™ Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
- News
Inventiva Strengthens Board of Directors with Appointment of Three Distinguished Life Sciences Leaders
- News
Seven years: the journey behind Myricx's acquisition by Novartis
- News
Abivax Announces Closing of $920 Million Public Offering
- News
Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia
- News
Sofinnova Partners announces Myricx Bio agrees to be acquired by Novartis
- News
AFYREN announces the resumption of production at its plant after the successful technical shutdown
- News
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
- News
Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
- News
Biotalys Announces Retirement of Board Member Patrick Van Beneden